Related references
Note: Only part of the references are listed.The ASIC3-M-CSF-M2 macrophage-positive feedback loop modulates fibroblast-to-myofibroblast differentiation in skin fibrosis pathogenesis
Jun-Jie Wu et al.
CELL DEATH & DISEASE (2022)
Nanocomplexes loaded with miR-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K/AKT and MEK/ERK pathway
Xin Liu et al.
DRUG DELIVERY (2020)
Keloid and Hypertrophic Scar Formation, Prevention, and Management: Standard Review of Abnormal Scarring in Orthopaedic Surgery
Gregory Grabowski et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2020)
The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models
Grace C. Limandjaja et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Combined Therapeutic Strategies for Keloid Treatment
Young In Lee et al.
DERMATOLOGIC SURGERY (2019)
Animal Models for Studies of Keloid Scarring
Dorothy M. Supp
ADVANCES IN WOUND CARE (2019)
Verbascoside: Identification, Quantification, and Potential Sensitization of Colorectal Cancer Cells to 5-FU by Targeting PI3K/AKT Pathway
Yasmeen M. Attia et al.
SCIENTIFIC REPORTS (2018)
Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-B/iNOS signaling pathways
Yue Gao et al.
JOURNAL OF PINEAL RESEARCH (2017)
Pleiotropic FTY720 Is a Specific and Potent Therapy for Hypertrophic Scars
Fen Shi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
In Situ Cytokine Expression and Morphometric Evaluation of Total Collagen and Collagens Type I and Type III in Keloid Scars
Isabela Rios da Silva et al.
MEDIATORS OF INFLAMMATION (2017)
Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment
Brian Berman et al.
DERMATOLOGIC SURGERY (2017)
Cyclic AMP Effectors Regulate Myometrial Oxytocin Receptor Expression
Angela Yulia et al.
ENDOCRINOLOGY (2016)
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways
Wenbo Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis
Jung-Woo Kang et al.
JOURNAL OF PINEAL RESEARCH (2016)
Melatonin: the dawning of a treatment for fibrosis?
Wei Hu et al.
JOURNAL OF PINEAL RESEARCH (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds
Thitita Unahabhokha et al.
PHARMACEUTICAL BIOLOGY (2015)
Transcriptional Profiling of Rapamycin-Treated Fibroblasts From Hypertrophic and Keloid Scars
Victor W. Wong et al.
ANNALS OF PLASTIC SURGERY (2014)
Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions
Zhe Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
cAMP signalling in the normal and tumorigenic pituitary gland
R. Formosa et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Cyclic AMP sensor EPAC proteins and energy homeostasis
Muayad Almahariq et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
Chang-Min Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
PKA: Lessons learned after twenty years
Susan S. Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity
Farhatullah Syed et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Keloid Disease Can Be Inhibited by Antagonizing Excessive mTOR Signaling With a Novel Dual TORC1/2 Inhibitor
Farhatullah Syed et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells
Rajarshi Pal et al.
ARCHIVES OF TOXICOLOGY (2012)
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
Gerd G. Gauglitz et al.
MOLECULAR MEDICINE (2011)
Mechanisms of transforming growth factor β1/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts
S. He et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Molecular dissection of abnormal wound healing processes resulting in keloid disease
Barbara Shih et al.
WOUND REPAIR AND REGENERATION (2010)
Surgery and Perioperative Intralesional Corticosteroid Injection for Treating Earlobe Keloids: A Korean Experience
Jin Young Jung et al.
ANNALS OF DERMATOLOGY (2009)
Transforming growth factor-β1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture
R. Naim et al.
AESTHETIC PLASTIC SURGERY (2008)
Abnormal wound heating: keloids
David T. Robles et al.
CLINICS IN DERMATOLOGY (2007)
Transforming growth factor-β promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling
JJW Mulsow et al.
ANNALS OF SURGERY (2005)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
5-fluorouracil blocks transforming growth factor-β-induced α2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation
J Wendling et al.
MOLECULAR PHARMACOLOGY (2003)
Differential expression of transforming growth factor-β receptors I and II and activation of Smad 3 in keloid fibroblasts
GS Chin et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2001)
Share Paper
